OCULAR THERAPEUTIX, INC OCUL
OCULAR THERAPEUTIX, INC statistics & valuation
Market cap$2.2B
P / S41.5×
P / B3.3×
Net margin-511.9%
Return on equity-40.6%
FCF margin-417.5%
Return on capital-35.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -519.8% | -269.6% | -141.0% | -152.7% | -179.3% | -361.1% | -2029.9% | -2970.8% | -3220.1% | -2296.0% |
| Net margin | -511.9% | -303.7% | -138.1% | -138.0% | -15.1% | -894.3% | -2043.3% | -3014.0% | -3296.2% | -2369.0% |
| FCF margin | -417.5% | -213.4% | -130.6% | -123.0% | -153.4% | -312.6% | -1888.2% | -2568.6% | -3053.8% | -1903.6% |
| Return on assets | -32.9% | -42.3% | -32.0% | -47.6% | -3.2% | -59.4% | -109.7% | -82.1% | -114.4% | -59.7% |
| Return on equity | -40.6% | -61.4% | -88.6% | -200.8% | -7.4% | -204.5% | 2379.4% | -167.2% | -242.4% | -86.0% |
| Current ratio | 15.39 | 10.66 | 6.66 | 4.13 | 7.26 | 9.23 | 5.00 | 6.14 | 3.23 | 8.42 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.